Abstract: Micro-authorization of remote assistance for an autonomous vehicle is described herein. A constraint that inhibits propulsion by a mechanical system of the autonomous vehicle is activated by a computing system of the autonomous vehicle, wherein a signal that identifies the activated constraint is transmitted from the autonomous vehicle to a remote computing system. The remote computing system generates instructions to deactivate the activated constraint. A return signal is transmitted from the remote computing system that specifies instructions to deactivate the constraint and a distance to desirably advance the autonomous vehicle. The computing system of the autonomous vehicle deactivates the constraint and the mechanical system is controlled to advance the autonomous vehicle when signal latency is less than a predetermined threshold duration of time.

Abstract: Micro-authorization of remote assistance for an autonomous vehicle is described herein. A constraint that inhibits propulsion by a mechanical system of the autonomous vehicle is activated by a computing system of the autonomous vehicle, wherein a signal that identifies the activated constraint is transmitted from the autonomous vehicle to a remote computing system. The remote computing system generates instructions to deactivate the activated constraint. A return signal is transmitted from the remote computing system that specifies instructions to deactivate the constraint and a distance to desirably advance the autonomous vehicle. The computing system of the autonomous vehicle deactivates the constraint and the mechanical system is controlled to advance the autonomous vehicle when signal latency is less than a predetermined threshold duration of time.

Abstract: An occlusion device having a lumen defined therethrough and a saddle narrower than saddles of prior occlusion devices or stents to allow provision of an occlusion element with respect to a portion of the saddle to occlude flow of materials through the saddle. The inner diameter of the narrowed saddle may be 6 mm or less. The occlusion element may be formed from a material which plugs a portion of the occlusion device lumen extending through the saddle and/or which restrains a portion of the saddle from expanding thereby occluding flow of materials therethrough. The remainder of the saddle and/or inwardly facing surfaces of at least one retention member extending outwardly along an end of the saddle may be configured to promote tissue ingrowth, such as by remaining uncoated.

Abstract: An implantable device having an expandable element, such as a balloon, exerting a radially-outwardly directed anti-migration force to hold the implantable device in place. The implantable device occlusion device may be an occlusion device configured to be inserted through a body passage. The implantable device may include a first component and a second component expandable within a lumen of the first component to exert an antimigration force against the first component. The first component may be an expandable stent coated to resist tissue ingrowth, and the second component may be an expandable balloon configured to exert an anti-migration force against the expandable stent.

Abstract: The present disclosure is directed to combining the strengths of different methods of analyzing collected sensor data to updating a driving pattern of an automated vehicle (AV). This may include combining data from sets of data that track movement of objects over time with instantaneously received sensor data based on a series of steps that include accessing data that tracks the motion of objects in the field of view of a sensing apparatus, receiving current sensor data that includes a component of current or instantaneous object motion, and identifying whether controls of AV should be maintained or changed. When controls of the AV are maintained, an AV may be controlled to stay in driving in a same lane of a roadway at a same velocity. When controls of an AV are changed, changes may include applying, increasing a velocity, or altering the course of the AV.

Abstract: The present disclosure is directed to focusing processing resources of a radar apparatus to radar data associated with specific locations around an autonomous vehicle (AV). Data associated with a type of sensing apparatus that is not a radar (e.g. a camera and/or a LiDAR apparatus) that tracks motion of specific objects around the AV may be used by a processor to identify specific sets of radar data to process. Locations associated with a specific set of tracked objects may be used to identify sets of received radar signals that will be processed by the radar apparatus. Radar signals received by the radar apparatus that are associated with locations that do not correspond to a location of a tracked object may be ignored by the radar apparatus to reduce a number of computational tasks that a processor of the radar apparatus must process.

Abstract: The present disclosure relates generally to a soluble dietary fiber, and related methods and products. The soluble dietary fiber possesses enhanced properties relative to conventional soluble dietary fibers, including a small median particle size and narrow particle size distribution.

Abstract: Micro-authorization of remote assistance for an autonomous vehicle is described herein. A constraint that inhibits propulsion by a mechanical system of the autonomous vehicle is activated by a computing system of the autonomous vehicle, wherein a signal that identifies the activated constraint is transmitted from the autonomous vehicle to a remote computing system. The remote computing system generates instructions to deactivate the activated constraint. A return signal is transmitted from the remote computing system that specifies instructions to deactivate the constraint and a distance to desirably advance the autonomous vehicle. The computing system of the autonomous vehicle deactivates the constraint and the mechanical system is controlled to advance the autonomous vehicle when signal latency is less than a predetermined threshold duration of time.

Abstract: Micro-authorization of remote assistance for an autonomous vehicle is described herein. A constraint that inhibits propulsion by a mechanical system of the autonomous vehicle is activated by a computing system of the autonomous vehicle, wherein a signal that identifies the activated constraint is transmitted from the autonomous vehicle to a remote computing system. The remote computing system generates instructions to deactivate the activated constraint. A return signal is transmitted from the remote computing system that specifies instructions to deactivate the constraint and a distance to desirably advance the autonomous vehicle. The computing system of the autonomous vehicle deactivates the constraint and the mechanical system is controlled to advance the autonomous vehicle when signal latency is less than a predetermined threshold duration of time.

Abstract: A multi-family building structure using light weight prefabricated parallel modular living units is provided. The structure comprises at least first plurality of parallel modular living units and a second plurality of parallel modular living units. Each living unit in the first plurality of living units comprises a first outer and inner modules and a first synthetic residential module between the first outer module and the first inner module. Each living unit in the first plurality of living units comprises a second outer and outer modules and a second synthetic residential module between the second outer module and the second inner module. The structure further comprises a synthetic corridor module formed between the first inner module of the each living unit in the first plurality of living units and the second inner module in the second plurality of living units.

Abstract: Micro-authorization of remote assistance for an autonomous vehicle is described herein. A constraint that inhibits propulsion by a mechanical system of the autonomous vehicle is activated by a computing system of the autonomous vehicle, wherein a signal that identifies the activated constraint is transmitted from the autonomous vehicle to a remote computing system. The remote computing system generates instructions to deactivate the activated constraint. A return signal is transmitted from the remote computing system that specifies instructions to deactivate the constraint and a distance to desirably advance the autonomous vehicle. The computing system of the autonomous vehicle deactivates the constraint and the mechanical system is controlled to advance the autonomous vehicle when signal latency is less than a predetermined threshold duration of time.

Abstract: In general, certain embodiments of the present disclosure provide methods and systems for object detection by a neural network comprising a convolution-nonlinearity step and a recurrent step. In a training mode, a dataset is passed into the neural network, and the neural network is trained to accurately output a box size and a center location of an object of interest. The box size corresponds to the smallest possible bounding box around the object of interest and the center location corresponds to the location of the center of the bounding box. In an inference mode, an image that is not part of the dataset is passed into the neural network. The neural network automatically identifies an object of interest and draws a box around the identified object of interest. The box drawn around the identified object of interest corresponds to the smallest possible bounding box around the object of interest.

Abstract: Molecular constructs and dual recognition constructs having a sequence encoding a TCR affinity weakening motif, and DNA and RNA sequences corresponding thereto, are presented. Modified T-cells and other cells transformed with the molecular contracts express a modified TCR that imparts a reduction, in non-specific binding, -an enhancement of binding specificity and an enhancement of binding affinity for a target antigen, compared to non-transformed (wild-type, native) T-cells, are described. The modified TCRs possess an affinity enhancing motif and an affinity weakening motif. Methods of transforming cells and methods of using enriched populations of transformed cells, in the treatment of cancer and infections arid T-cell mediated pathologies are provided. The affinity weakening motif imparts a weakened interaction, of a TCR with major histocompatibility complex proteins, such as HLA proteins in humans.

Abstract: In general, certain embodiments of the present disclosure provide methods and systems for object detection by a neural network comprising a convolution-nonlinearity step and a recurrent step. In a training mode, a dataset is passed into the neural network, and the neural network is trained to accurately output a box size and a center location of an object of interest. The box size corresponds to the smallest possible bounding box around the object of interest and the center location corresponds to the location of the center of the bounding box. In an inference mode, an image that is not part of the dataset is passed into the neural network. The neural network automatically identifies an object of interest and draws a box around the identified object of interest. The box drawn around the identified object of interest corresponds to the smallest possible bounding box around the object of interest.

Abstract: In general, certain embodiments of the present disclosure provide methods and systems for object detection by a neural network comprising a convolution-nonlinearity step and a recurrent step. In a training mode, a dataset is passed into the neural network, and the neural network is trained to accurately output a box size and a center location of an object of interest. The box size corresponds to the smallest possible bounding box around the object of interest and the center location corresponds to the location of the center of the bounding box. In an inference mode, an image that is not part of the dataset is passed into the neural network. The neural network automatically identifies an object of interest and draws a box around the identified object of interest. The box drawn around the identified object of interest corresponds to the smallest possible bounding box around the object of interest.

Abstract: A multi-family building structure using prefabricated parallel modular living units is provided. The structure comprises at least first plurality of parallel modular living units and a second plurality of parallel modular living units. Each living unit in the first plurality of living units comprises a first outer and inner modules and a first synthetic residential module between the first outer module and the first inner module. Each living unit in the first plurality of living units comprises a second outer and outer modules and a second synthetic residential module between the second outer module and the second inner module. The structure further comprises a synthetic corridor module formed between the first inner module of the each living unit in the first plurality of living units and the second inner module in the second plurality of living units. The outer modules and the inner modules are devoid of redundant side walls.

Abstract: Molecular constructs and dual recognition constructs having a sequence encoding a TCR affinity weakening motif, and DNA and RNA sequences corresponding thereto, are presented. Modified T-cells and other cells transformed with the molecular contracts express a modified TCR that imparts a reduction, in non-specific binding, an enhancement of binding specificity and an enhancement of binding affinity for a target antigen, compared to non-transformed (wild-type, native) T-cells, are described. The modified TCRs possess an affinity enhancing motif and an affinity weakening motif. Methods of transforming cells and methods of using enriched populations of transformed cells, in the treatment of cancer and infections arid T-cell mediated pathologies are provided. The affinity weakening motif imparts a weakened interaction, of a TCR with major histocompatibility complex proteins, such as HLA proteins in humans.